Mayo - Cardiac Amyloid AI

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/30

flashcard set

Earn XP

Description and Tags

Vocabulary flashcards summarizing core terms related to echocardiographic features, diagnostic work-up, genetic variants, prognostic markers, and emerging treatments in cardiac amyloidosis.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

31 Terms

1
New cards

Cardiac Amyloidosis

Infiltrative cardiomyopathy caused by misfolded protein deposition (AL or TTR) leading to thickened, stiff ventricular walls and heart failure.

2
New cards

AL (Light-Chain) Amyloidosis

Amyloid formed from immunoglobulin light chains; originates in bone marrow and is rapidly progressive, often requiring hematology-directed therapies (e.g., stem cell transplant).

3
New cards

TTR (Transthyretin) Amyloidosis

Amyloid derived from misfolded transthyretin made in the liver; exists as wild-type (senile) or hereditary mutant forms.

4
New cards

Wild-Type TTR

Non-mutated transthyretin that aggregates with age; now the most common amyloid seen in clinics, often presenting with HFpEF, carpal tunnel, and AFib.

5
New cards

Hereditary TTR (ATTRm)

Mutant transthyretin causing earlier amyloid deposition; the V122I (Val122Ile) variant affects ≈4 % of African Americans.

6
New cards

Monoclonal Gammopathy of Undetermined Significance (MGUS)

Asymptomatic clonal plasma-cell disorder that can evolve into AL amyloidosis; presence mandates tissue biopsy before labeling TTR by scan.

7
New cards

Technetium-99m PYP Scan

Bone scintigraphy that binds myocardial TTR deposits; grade 2–3 uptake with absent monoclonal protein is diagnostic for TTR amyloid.

8
New cards

Relative Apical Sparing ("Cherry-on-Top")

Speckle-tracking strain pattern with preserved apical strain and reduced basal/mid strain; suggestive, but not pathognomonic, for cardiac amyloid.

9
New cards

Stroke Volume Index (SVI)

SV normalized to body surface area; in AL amyloid, SVI ≤ 33 mL/m² predicts survival < 5 months, whereas > 33 mL/m² predicts ≈65 months.

10
New cards

Cardiac Index

Cardiac output/body surface area; helpful for hemodynamic assessment in amyloid patients.

11
New cards

LV Wall Thickness ≥ 12 mm

Echo threshold suggesting infiltrative disease when hypertensive or athletic hypertrophy is absent.

12
New cards

Low-Voltage ECG

Disproportionately small QRS amplitudes despite thick myocardium; classic but not universal finding in amyloidosis.

13
New cards

Basal Posterior Wall Thickening

Echo clue to amyloid; often accompanied by right-ventricular free-wall thickening.

14
New cards

Periorbital Purpura

Characteristic raccoon-eye bruising linked to AL amyloidosis.

15
New cards

Carpal Tunnel Syndrome

Median nerve entrapment frequently preceding TTR amyloid diagnosis.

16
New cards

TAVR and Amyloid

≈15 % of severe AS patients undergoing TAVR have coexistent TTR amyloid; TAVR still indicated and beneficial.

17
New cards

Serum & Urine Immunofixation Electrophoresis

First-line laboratories to exclude AL amyloid by detecting monoclonal light chains.

18
New cards

Endomyocardial Biopsy

Gold standard when imaging and labs are inconclusive or monoclonal protein present.

19
New cards

Tafamidis

Oral TTR tetramer stabilizer reducing mortality and hospitalizations in ATTR cardiomyopathy (Class I guideline).

20
New cards

AG10 (Acoramidis)

Next-generation oral TTR stabilizer currently in late-phase trials.

21
New cards

Patisiran & Inotersen

RNA-silencing agents that inhibit hepatic TTR production; approved for neuropathic ATTR and being studied in cardiac disease.

22
New cards

TTR Gene Silencers vs Stabilizers

Silencers reduce protein synthesis (injectable, infrequent dosing); stabilizers prevent tetramer dissociation (oral, daily).

23
New cards

NYHA Class and Prognosis

Early-stage (Class I–II) ATTR patients on therapy show ~60 % 82-month survival vs ~25 % when treated at Class III.

24
New cards

Anticoagulation in Amyloid

AFib carries high stroke risk; DOAC or warfarin recommended regardless of CHA₂DS₂-VASc score.

25
New cards

Echocardiographic Response Criteria

≥5 % change in EF or ≥5 mL change in stroke volume considered significant during follow-up.

26
New cards

Cardiac MRI (CMR)

Provides tissue characterization (T1 mapping, ECV) and functional data; useful for diagnosis and potentially for early detection.

27
New cards

Bone Scintigraphy Limitations

Useful for TTR, not AL; false positives occur with coexistent MGUS—biopsy required.

28
New cards

Right-Ventricular Free-Wall Thickening

Additional echo sign raising suspicion for infiltrative amyloid when seen with LV thickening.

29
New cards

Pericardial Effusion

Small effusion commonly accompanies amyloid due to stiff ventricles and elevated right-sided pressures.

30
New cards

Cherry-on-Top Positive Predictive Value

In a single-center study, apical sparing strain pattern predicted amyloid in only 39 % of patients—imaging must be correlated clinically.

31
New cards

Dimer vs Tetramer Misfolding

TTR normally circulates as a tetramer; misfolding/monomer dissociation leads to amyloid formation.